Lobbying Information
Subject Matters
- Aboriginal Affairs
- Arts and Culture
- Budget
- Economic Development
- Employment and Training
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Development
- International Relations
- International Trade
- Regional Development
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Commemoration of the 100th anniversary of the discovery of insulin in Canada.
- Support the establishment of a life sciences strategy in Canada
Policies or Program, Regulation
- Impact of Patented Medicine Prices Review Board reform on the life sciences sector.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canada Foundation for Innovation
-
Canadian Heritage (PCH)
-
Canadian Human Rights Tribunal (CHRT)
-
Canadian Institutes of Health Research (CIHR)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
National Research Council (NRC)
-
Parks Canada (PC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
In-house Organization Details
Description of the organization's activities
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
Responsible officer name and position during the period of this registration
Béatrice Clerc,
President
Organization's membership or classes of membership
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in 170 countries.
Government funding
No government funding was received during the last completed financial year.
In-house Organization Contact Information
Address:
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada
Telephone number:
905-629-4222
Lobbyists Details
Employees who lobby for the organization
- Gabrielle Berard,
Senior Manager, External Affairs |
Designated public offices held
- Michael Tucker,
Patient Access Manager, Atlantic |
No public offices held
